Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 228

Results For "FY"

2436 News Found

Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials
Biotech | October 11, 2021

Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials

VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials


Alnylam partners with the Medicines Manufacturing Innovation Centre
Biotech | October 09, 2021

Alnylam partners with the Medicines Manufacturing Innovation Centre

Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies


ASU drug manufacturing licence goes online
Policy | October 09, 2021

ASU drug manufacturing licence goes online

The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence


Lincoln Pharma gets Australian TGA approval
News | October 08, 2021

Lincoln Pharma gets Australian TGA approval

The company plans to expand its portfolio in regulated markets aggressively


Paediatric healthcare platform Health Basix raises seed fund
Startup | October 06, 2021

Paediatric healthcare platform Health Basix raises seed fund

The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families


Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Public Health | October 06, 2021

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

A total of 8308 stores are open across India and medicines are priced at affordable rates


Veeda Clinical Research files DRHP for Rs 831 crore IPO
News | October 01, 2021

Veeda Clinical Research files DRHP for Rs 831 crore IPO

The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders


WHO new Essential Medicines Lists focus on diabetes and cancer
Public Health | September 30, 2021

WHO new Essential Medicines Lists focus on diabetes and cancer

The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all


Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
Drug Approval | September 30, 2021

Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK

Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis


Roche launches cobas pure integrated solutions analyser
Medical Device | September 30, 2021

Roche launches cobas pure integrated solutions analyser

Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology